Rigosertib
CAS: 1225497-78-8
Rif. 3D-FR137713
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta |
Informazioni sul prodotto
- ON-01910
Rigosertib is a small molecule that inhibits the activity of the protein ErbB2. It has been shown to induce reactive oxygen species (ROS) and inhibit tumor growth in preclinical models. Rigosertib is being investigated as an investigational agent for cancer therapeutics. It has been shown to be well tolerated in animals and humans with minimal toxicity. Rigosertib prevents cell-cell interactions by binding to EGFR, which may have therapeutic potential in squamous cell carcinomas and melanoma cells. Rigosertib also inhibits the activity of tyrosine kinases and may be useful for treatment of cancers that are resistant to other therapies, such as coumarin derivatives, which are used in combination with chemotherapy for treatment of acute myeloid leukemia. RIGSERTIB blocks tumor growth by inducing apoptosis through activation of caspase-3 and caspase-7 pathways, which causes DNA fragmentation, nuclear condensation, and cleavage of poly
Proprietà chimiche
Richiesta tecnica su: 3D-FR137713 Rigosertib
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
